Open Insulin

Open Insulin

Open Insulin is a team of Bay Area biohackers working on simpler, less expensive ways to make insulin. The Open Insulin Project aims to develop a freely available, open protocol for insulin production to give diabetics access to low-cost insulin.

All edits by  Meredith Hanel 

Edits on 5 June, 2019
Meredith Hanel
Meredith Hanel edited on 5 June, 2019 7:46 pm
Edits made to:
Article (+187/-130 characters)
People (+3 rows) (+3 cells) (+44 characters)
Further reading (+2 rows) (+8 cells) (+314 characters)

Article

The Open Insulin Project team are biohackers developing a freely available, open protocol for insulin production. The group aims to make insulin more widely available to diabetics to reduce the number of people suffering from complications that result from diabetes that goes untreated with insulin such as blindness, cardiovascular disease, amputations and nerve and kidney damage. Scientific research performed by the Open Insulin Project could lay the groundwork to enable a generic drug company to make low-cost insulin. Open Insulin is researching methods toof generatedgenerating insulin that do not infringe on patents and that can be made publicly available. The group is considering making their recipe for making insulin open-source and providing it to hospitals and other patient-oriented groups that could make insulin themselves.

...

The Open Insulin Project was founded by Anthony Di Franco in 2015. Di Franco is a computer scientist who has Type I diabetes. The group works out of Counter Culture Labs in Oakland. Other groups participating in the Open Insulin Project include ReaGent in Ghent, Belgium, BioFoundry in Sydney, Australia and collaborators in Senegel, Cameroon and Zimbabwe. In December 2015 the project raised $16,656 on experiment.com.

...

The group attempted to produce insulin in E. coli bacteria, like the method used by drug manufacturers, but were not successful. Open Insulin switched to producing insulin in yeast. French biochemist, Yann Huon de Kermadec is in charge of the manufacturing process. Di Franco plans to inject himself with the insulin produced in their lab, once they have shown they have pure insulin.

People

Name
Role
Related Golden topics

Maria Chavez

Noel Carrascal

Patrik D'haeseleer

Further reading

Title
Author
Link
Type
Date

Biohackers With Diabetes Are Making Their Own Insulin

Dana G Smith

Web

May 30, 2019

The Open Insulin Project: A Case Study for 'Biohacked' Medicines

Web

Meredith Hanel
Meredith Hanel edited on 5 June, 2019 7:22 pm
Edits made to:
Description (+145/-7 characters)
Article (+1463 characters)
People (+3 rows) (+4 cells) (+62 characters)
Categories (+1 topics)
Topic thumbnail

Open Insulin

Open Insulin is a team of Bay Area biohackers working on newer, simpler, less expensive ways to make insulin. The Open Insulin Project aims to develop a freely available, open protocol for insulin production to give diabetics access to low-cost insulin.

Article

The Open Insulin Project team are biohackers developing a freely available, open protocol for insulin production. The group aims to make insulin more widely available to diabetics to reduce the number of people suffering from complications that result from diabetes that goes untreated with insulin such as blindness, cardiovascular disease, amputations and nerve and kidney damage. Scientific research performed by the Open Insulin Project could lay the groundwork to enable a generic drug company to make low-cost insulin. Open Insulin is researching methods to generated insulin that do not infringe on patents and that can be made publicly available. The group is considering making their recipe for making insulin open-source and providing it to hospitals and other patient-oriented groups that could make insulin themselves.

The Open Insulin Project was founded by Anthony Di Franco in 2015. Di Franco is a computer scientist who has Type I diabetes. The group works out of Counter Culture Labs in Oakland. In December 2015 the project raised $16,656 on experiment.com.

The group attempted to produce insulin in E. coli bacteria, like the method used by drug manufacturers, but were not successful. Open Insulin switched to producing insulin in yeast. French biochemist, Yann Huon de Kermadec is in charge of the manufacturing process. Di Franco plans to inject himself with the insulin produced in their lab, once they have shown they have pure insulin.

People

Name
Role
Related Golden topics

Anthony Di Franco

Founder

Thornton Thompson

Yann Huon de Kermadec

Categories

No more activity to show.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.